In a report released yesterday, Marie Thibault from BTIG reiterated a Buy rating on Atricure (ATRC – Research Report), with a price target of ...
Investors might want to bet on AtriCure (ATRC), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...
2025 Adjusted EBITDA Guidance: $42 million to $44 million. AtriCure Inc (NASDAQ:ATRC) achieved a 17% revenue growth in 2024, reaching $465 million, with strong performance in pain management ...
Shares of ATRC opened at $40.94 on Thursday. The stock’s 50 day moving average is $35.76 and its two-hundred day moving average is $31.43. The firm has a market capitalization of $2.00 billion ...
Initial advanced air mobility (AAM) regulations under development for the UAE GCAA and ATRC entities – TII and ASPIRE collaborate on technical expertise and airspace management The UAE has taken ...
Shares of ATRC opened at $40.94 on Thursday. AtriCure has a 1 year low of $18.94 and a 1 year high of $43.11. The company has a current ratio of 3.62, a quick ratio of 2.59 and a debt-to-equity ...
The General Civil Aviation Authority (GCAA) has partnered with the Advanced Technology Research Council (ATRC) entities—Technology Innovation Institute (TII) and ASPIRE—to implement the initiative, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results